Pulmonary
- Critical Care Associates
of East Texas
Jeffrey M.
Shea, M.D., F.C.C.P.
Catherine M. Martinez, M.D.
|
Jeffrey M.
Shea, M.D., F.C.C.P. |
|
About
Our Practice
Patient
Information
Critical Care
Procedure Photos
Advanced Directives
BET
Program
What's New
|
*** This Medication is no longer available (except under special circumstances) ***
COMMON BRAND NAME(S): Propulsid USES: This medication is used to treat symptoms of nighttime heartburn due to reflux disease. This drug will no longer be marketed in the US after July 14, 2000. Since the drugs approval in 1993, serious arrhythmias, including ventricular tachycardia, ventricular fibrillation, torsades de pointes, and QT prolongation have been documented in patients prescribed Propulsid. Over 340 cases of serious arrhythmias have been reported between 1993 and 1999, including 80 fatalities. It has been concluded that continued general access to propulsid poses unacceptable risks. Physicians treating patients with severely debilitating conditions in whom they feel the benefits of propulsid therapy may potentially outweigh the associated risks may contact Janssen Pharmaceutica. The company will continue to make the drug available for patients who satisfy specific eligibility criteria for a limited-access protocol. Web sites related to Propulsid: |
|
